Each year, one of the featured sessions at the ASHP Midyear Clinical Meeting is the highly regarded "pearls" program which includes presentations by pharmacists who share their wisdom borne of experience. ASHP's Clinical Pearls is edited by Bruce Canaday, the original creator of the MCM pearls concept and the session chair for the 2007 presentations. The authors were drawn from the presenters and invited to participate in this year's published version. This collection provides numerous examples of interventions that have improved clinical pharmacy practice in various U.S. and foreign health systems. It also describes the historical context within which the present need for safety and quality initiatives has arisen.

ASHP’s Informatics Pearls is a compilation of expanded versions of original sessions from the 2006 and 2007 ASHP Midyear Clinical Meetings. The pearls presented will help identify how pharmacy informatics programs can be utilized in your hospital system to improve patient care. It will also compare various pharmacy informatics programs and how they improve the medication-use system. Expanded topics from the Informatics Pearls sessions include topics on: The transition from paper to online forms Barcode uses Training on a new health care system technology And much more.

One of the significant values of the “pearls” is to show the creative ways that issues were approached, and solutions reached. Many variations in practice setting present themselves (hospital size, location, patient base, etc.) but the value of creative approaches to problems has a universal appeal. Management Pearls is edited by Deborah Ash who was the session chair for the 2007 presentations. The publication provides a number of examples of tools, techniques, and interventions that have improved pharmacy management in both U.S. and foreign health systems.

Capturing the creative spirit and real-world content of the live Pearls sessions, this collection outlines several examples of innovative approaches to improve patient safety and quality.

ASHP s Safety and Quality Pearls is one of the most popular sessions at the ASHP Midyear Clinical Meeting, and the 2007 and 2008 sessions were no different. Now with in its second volume, ASHP s Safety and Quality Pearls 2 pulls together 17 of the original presentations offered at these sessions. "

This book provides instruction for health professionals wanting to gain knowledge about the clinical aspects of cannabis medicine. How to use cannabis with real patients, not just theoretically, its pitfalls and challenges, as well as rewards, is a vastly under-covered topic. Now that some form of medical cannabis is approved in almost all US states, health care providers and patients Need to Know how to achieve maximum benefits by best use of this versatile herbal medicine. Medicinal Cannabis: Pearls for Clinical Practice introduces the scientific background of how cannabis acts medicinally, its components and how cannabis affects a specific condition. Key Features: Provides instruction for health professionals wanting to understand the clinical practice of cannabis medicine Reviews the chemistry, physiology and mechanisms of action of cannabinoids, endocannabinoids and cannabis with a focus on clinical relevance Presents information on practice management of specific patient populations, including pediatric, youth, adult, elderly and pets Features over 150 case reports with learning "Pearls" from the author’s clinical practice for 35 medical conditions Discusses specifics of dosing and delivery of cannabis in detail, with strategies to promote the benefit/risk ratio About the Author Deborah Malka, MD, PhD, is a holistic physician with certification in Integrative Holistic Medicine. Prior to clinical practice, Dr. Malka completed her PhD in Human Genetics from Columbia University, and studied both natural and traditional medicine, with degrees from the University of New Mexico School of Medicine and the Santa Fe College of Natural Medicine. She has specialized in cannabis medicine for the past 15 years, treating over 30,000 patients.

Anticoagulants can be dangerous drugs. Developed to save lives by preventing and treating thrombosis, these widely used medications are linked to unacceptable levels of morbidity and mortality. According to a study by the Institute for Safe Medication Practices, 8.2% of hospitalized patients on warfarin and 13.6% exposed to heparin experience an adverse drug event. To prevent these events from occurring, clinicians monitor anticoagulation therapy closely. But there are still questions. What is the risk of stroke in a patient who has specified CHADS2 risk factors? What is the recommended perioperative treatment? Find life-saving solutions quickly to these challenges and more with Anticoagulation Therapy: A Point-of-Care Guide, edited by William Dager, Michael Gulseth, and Edith Nutescu. This concise reference is designed with the busy clinician and resident in mind. It provides a quick way to access necessary clinical and therapeutic information that has the potential to improve the lives when many risk factors are at play and time is of the essence. Inside you’ll find: Quick reference elements such as tables figures to easily access key information Clinical pearls and bullets to highlight real life application Selected guideline statements from leading organizations 19 chapters covering a broad range of topics The second book in the Point-of-Care series, Anticoagulation Therapy is led by a team of editors with more than 77 combined years of clinical experience, including insight from 19 contributors. The book is divided into three sections, including: Anticoagulation Medication Management, Conditions Requiring Anticoagulation Therapy, and Practical Monitoring and Coagulation Laboratory Insights.

The new science of pharmacogenomics aims to understand how an individual's genetic composition affects his/her response to a specific drug or class of drugs. By studying such characteristics as drug metabolizing enzymes, drug transporter activity, and receptor sensitivity, a pharmacist is better able to prescribe the right drug the first time.If you are pharmacist, resident, or student curious about this new field, start withConcepts in Pharmacogenomics. In this practical guide, you will find an overview of the science behind pharmacogenomics, followed by detailed chapters related to its clinical application and implementation.Features include: case studies in each chapter clinical pearls illustrations of key concepts figures, diagrams, and flow charts for visual learners key points summarized.